This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Pierre Fabre Medicament, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2012-2013.
Company Filing History:
2 out of 269 
1 out of 8,801 
Years Active: 2012-2013
Title: Paul Hellier: Innovator in Pharmaceutical Synthesis
Introduction
Paul Hellier is a notable inventor based in Castelnau de Montmiral, France. He has made significant contributions to the field of pharmaceutical synthesis, holding a total of 2 patents. His work focuses on innovative methods that enhance the production of important pharmaceutical compounds.
Latest Patents
One of his latest patents is a method for synthesizing a pharmaceutically acceptable acid addition salt of (1S, 2R)-milnacipran. This invention involves several intricate steps, including the reaction of phenylacetonitrile and (R)-epichlorhydrin, followed by a series of reactions that ultimately yield (1S, 2R)-milnacipran. Another patent involves the fluorinated derivatives of catharanthine, which respond to a specific general formula, showcasing his expertise in chemical synthesis.
Career Highlights
Throughout his career, Paul Hellier has worked with prominent companies such as Pierre Fabre Medicament and Commissariat à l'Énergie Atomique et aux Énergies Alternatives. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.
Collaborations
Paul has collaborated with notable coworkers, including Marc Nicolas and Emerson Giovanelli. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Paul Hellier's contributions to pharmaceutical synthesis through his patents and collaborations highlight his role as an influential inventor in the field. His innovative methods continue to impact the development of important pharmaceutical compounds.